Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Needles

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 293 participants.

Also called NCT01231984

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 293 participants (enrolled count) (from the registry)
Sponsor
Becton, Dickinson and Company (from the registry)
Registry
  • NCT NCT01231984
Other papers using this trial's data
  • Safety and efficacy of insulin therapy delivered via a 4mm pen needle in obese patients with diabetes Mayo Clinic proceedings, 2015-03 DOI, PubMed 25662503

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01231984. Randomized; no masking; primary purpose other. Start 2010-10 (registry gives no type); primary completion 2012-05 (actual). Results posted on 2014-06-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Needles
Condition
Diabetes Mellitus, Type 1
Condition
Diabetes Mellitus, Type 2
Intervention (Device)
4 mm x 32G Pen Needle
Intervention (Device)
8mm x 31G Pen Needle
Intervention (Device)
12.7mm x 29G Pen Needle
Lead sponsor
Becton, Dickinson and Company (class: industry)

Record details

Record id
cardio:ct-nct01231984
Content hash
03189081bc478527a78c0d359be760df8961116e923d69c7d1c3af3bbd33dee6